You have 9 free searches left this month | for more free features.

City

Austin (1)

Condition

Advanced Cancer (1)

Biliary Tract Neoplasms (1)

Gastric Cancer (1)

Gastroesophageal-junction Cancer (1)

Overall Status

Not yet recruiting (2)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Henan Cancer Hospital (1)

Mabspace Biosciences (Suzhou) Co., Ltd. (1)

Shanghai Zhongshan Hospital (1)

Collaborator

Transcenta Holding Limited (1)

Intervention

tst001 (3)

anrotinib (1)

capecitabine (1)

ibi315 (1)

oxaliplatin (1)

tqb2450 (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

tst001

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Biliary Tract Tumors Trial (TST001)

Not yet recruiting

Biliary Tract Neoplasms

TST001

(no location specified)

Dec 28, 2021

Gastric Cancer, Gastroesophageal-junction Cancer Trial (IBI315, Oxaliplatin, Capecitabine)

Not yet recruiting

Gastric Cancer
Gastroesophageal-junction Cancer

IBI315
+5 more

(no location specified)

Nov 2, 2022

Advanced Cancer Trial in Austin (TST001)

Recruiting

Advanced Cancer

TST001

Austin, Texas

NEXT Oncology

Jun 8, 2020